334 related articles for article (PubMed ID: 31669585)
1. Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.
Cornell KA; Knippel RJ; Cortright GR; Fonken M; Guerrero C; Hall AR; Mitchell KA; Thurston JH; Erstad P; Tao A; Xu D; Parveen N
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129455. PubMed ID: 31669585
[TBL] [Abstract][Full Text] [Related]
2. Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method.
Cornell KA; Primus S; Martinez JA; Parveen N
J Antimicrob Chemother; 2009 Jun; 63(6):1163-72. PubMed ID: 19376840
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of substrate specificity in 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases.
Siu KK; Asmus K; Zhang AN; Horvatin C; Li S; Liu T; Moffatt B; Woods VL; Howell PL
J Struct Biol; 2011 Jan; 173(1):86-98. PubMed ID: 20554051
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in
Chakraborti M; Schlachter S; Primus S; Wagner J; Sweet B; Carr Z; Cornell KA; Parveen N
Pathogens; 2020 Aug; 9(9):. PubMed ID: 32825529
[TBL] [Abstract][Full Text] [Related]
5. Substrate preference of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase in Burkholderia thailandensis.
Gao Q; Zheng D; Yuan Z
FEMS Microbiol Lett; 2013 Feb; 339(2):110-6. PubMed ID: 23198993
[TBL] [Abstract][Full Text] [Related]
6. Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.
Mosel MR; Carolan HE; Rebman AW; Castro S; Massire C; Ecker DJ; Soloski MJ; Aucott JN; Eshoo MW
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036693
[No Abstract] [Full Text] [Related]
7. Femtomolar transition state analogue inhibitors of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli.
Singh V; Evans GB; Lenz DH; Mason JM; Clinch K; Mee S; Painter GF; Tyler PC; Furneaux RH; Lee JE; Howell PL; Schramm VL
J Biol Chem; 2005 May; 280(18):18265-73. PubMed ID: 15749708
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent Proteins, Promoters, and Selectable Markers for Applications in the Lyme Disease Spirochete Borrelia burgdorferi.
Takacs CN; Kloos ZA; Scott M; Rosa PA; Jacobs-Wagner C
Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30315081
[TBL] [Abstract][Full Text] [Related]
9. Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
Pothineni VR; Potula HSK; Ambati A; Mallajosyula VVA; Sridharan B; Inayathullah M; Ahmed MS; Rajadas J
Sci Rep; 2020 Mar; 10(1):3798. PubMed ID: 32123189
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
Johnson RC; Kodner CB; Jurkovich PJ; Collins JJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2133-6. PubMed ID: 2073103
[TBL] [Abstract][Full Text] [Related]
11. Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.
Pothineni VR; Wagh D; Babar MM; Inayathullah M; Solow-Cordero D; Kim KM; Samineni AV; Parekh MB; Tayebi L; Rajadas J
Drug Des Devel Ther; 2016; 10():1307-22. PubMed ID: 27103785
[TBL] [Abstract][Full Text] [Related]
12. Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
Feng J; Shi W; Zhang S; Zhang Y
Emerg Microbes Infect; 2015 Jun; 4(6):e31. PubMed ID: 26954881
[TBL] [Abstract][Full Text] [Related]
13. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells.
Sharma B; Brown AV; Matluck NE; Hu LT; Lewis K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4616-24. PubMed ID: 26014929
[TBL] [Abstract][Full Text] [Related]
14. Structure of Staphylococcus aureus 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.
Siu KK; Lee JE; Smith GD; Horvatin-Mrakovcic C; Howell PL
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 May; 64(Pt 5):343-50. PubMed ID: 18453700
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
Caol S; Divers T; Crisman M; Chang YF
BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
[TBL] [Abstract][Full Text] [Related]
16. Age-Related Differential Stimulation of Immune Response by
Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
Front Immunol; 2018; 9():2891. PubMed ID: 30619263
[TBL] [Abstract][Full Text] [Related]
17. Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.
Wu X; Sharma B; Niles S; O'Connor K; Schilling R; Matluck N; D'Onofrio A; Hu LT; Lewis K
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126963
[No Abstract] [Full Text] [Related]
18. A selective antibiotic for Lyme disease.
Leimer N; Wu X; Imai Y; Morrissette M; Pitt N; Favre-Godal Q; Iinishi A; Jain S; Caboni M; Leus IV; Bonifay V; Niles S; Bargabos R; Ghiglieri M; Corsetti R; Krumpoch M; Fox G; Son S; Klepacki D; Polikanov YS; Freliech CA; McCarthy JE; Edmondson DG; Norris SJ; D'Onofrio A; Hu LT; Zgurskaya HI; Lewis K
Cell; 2021 Oct; 184(21):5405-5418.e16. PubMed ID: 34619078
[TBL] [Abstract][Full Text] [Related]
19. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
Preac-Mursic V; Weber K; Pfister HW; Wilske B; Gross B; Baumann A; Prokop J
Infection; 1989; 17(6):355-9. PubMed ID: 2613324
[TBL] [Abstract][Full Text] [Related]
20. Public health impact of strain specific immunity to Borrelia burgdorferi.
Khatchikian CE; Nadelman RB; Nowakowski J; Schwartz I; Levy MZ; Brisson D; Wormser GP
BMC Infect Dis; 2015 Oct; 15():472. PubMed ID: 26503011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
